Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Income from Continuing Operations: 2023-2024

Historic Income from Continuing Operations for Camp4 Therapeutics (CAMP) over the last 2 years, with Dec 2024 value amounting to -$51.8 million.

  • Camp4 Therapeutics' Income from Continuing Operations rose 1.90% to -$13.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$51.6 million, marking a year-over-year decrease of 0.41%. This contributed to the annual value of -$51.8 million for FY2024, which is 5.07% down from last year.
  • As of FY2024, Camp4 Therapeutics' Income from Continuing Operations stood at -$51.8 million, which was down 5.07% from -$49.3 million recorded in FY2023.
  • In the past 5 years, Camp4 Therapeutics' Income from Continuing Operations ranged from a high of -$49.3 million in FY2023 and a low of -$51.8 million during FY2024.
  • Moreover, its 2-year median value for Income from Continuing Operations was -$50.5 million (2023), whereas its average is -$50.5 million.
  • Data for Camp4 Therapeutics' Income from Continuing Operations shows a maximum YoY decreased of 5.07% (in 2024) over the last 5 years.
  • Camp4 Therapeutics' Income from Continuing Operations (Yearly) stood at -$49.3 million in 2023, then declined by 5.07% to -$51.8 million in 2024.